Anmed Health Medical Center
Anderson, South Carolina 29621
2 studies enrolling now · 15 studies all time
What they study most
ARDS, Acute Lung Injury, COVID-19 Pneumonia, Cardiovascular Diseases, Chronic Kidney Diseases, Combined Pulmonary Fibrosis and Emphysema, Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease, Coronary Stenosis, Diabetes Mellitus, Heart Failure
Studies at this site
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
- Prevail Global Study — Recruiting now
- SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Running, not enrolling
- Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States — Completed
- A Registry for Patients Taking Uptravi — Completed
- A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH) — Completed
- Absorb IV Randomized Controlled Trial — Completed
- Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE — Completed
- Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury — Completed
- A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear) — Completed
- Medtronic Resolute Onyx 2.0 mm Clinical Study — Completed
- Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study — Completed
- Guiding Evidence Based Therapy Using Biomarker Intensified Treatment — Stopped early
- EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events — Completed
- Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries. — Completed